Tag: Australia

The Canadian pharmaceutical manufacturer says it is supplying 26 Australian clinics with naturally derived psilocybin and is targeting further growth ...

As psychedelic medicine moves towards pharmaceutical development, Incannex is attempting to take synthetic psilocybin through the clinical, regulatory and commercial ...

Emyria has begun treating its first patients at a new Sydney clinic, extending its Empax mental health services into New ...

Melbourne-based Entropy Neurodynamics is advancing an intravenous psilocin programme spanning binge eating disorder, depression and other neuropsychiatric conditions, with recent ...

Optimi Health has completed production of a new batch of 5mg naturally derived psilocybin capsules, with the same batch set ...

As psilocybin and MDMA move deeper into psychiatric research and clinical practice, the conversation is shifting from therapeutic promise towards ...

Entropy Neurodynamics has reported sustained improvements in treatment-resistant binge-eating disorder three months after patients received two infusions of its IV ...

Australian psychedelic medicine company Emyria Limited (ASX: EMD) has been selected by the US Food and Drug Administration (FDA) to ...

Emyria (ASX: EMD) is preparing to open its first Sydney clinic in September, with the company saying key operational milestones ...

BLS Pharmaceuticals Limited (ASX: BLS) has appointed Zivana Crestani as Strategic Partnership Director, adding to the company's commercial leadership as ...